BioNTech
Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agency authorize Moderna Inc's (MRNA.O) COVID-19 vaccine for children and teens aged 6 to 17 years of age. Around 77 million people in the ..
People at high risk of severe disease who have yet to get a second COVID-19 booster should not wait for next-generation, Omicron-targeted vaccines expected in the fall, five vaccine experts told Reuters. In many countries, including the United Sta..
On December 8, 2020, May Parsons, a Filipina nurse, became the first person in the UK to administer a COVID-19 vaccine (Pfizer/BioNTech) outside clinical trials. <blockquote class="twitter-tweet"><p lang="en" dir="..
Early trial results suggest tailor-made jabs could stop the deadly disease from returning The positive results of a new vaccine have raised hopes of a cure for pancreatic cancer. One of the deadliest cancers with limited treatment options, the sur..
Health guidelines set for pilgrimage to be attended by 1 million people Saudi Arabia has specified 10 vaccines against COVID-19 for pilgrims who will perform this year’s Hajj. The Saudi Health Ministry announced the names and required dos..
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Fourth vaccine dose protects vs Omicron for at least a mo..
China's Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates. With Friday's announceme..
A third dose of the COVID-19 vaccine from Pfizer Inc (PFE.N) and BioNTech (22UAy.DE) produced significant protection against the Omicron variant of the coronavirus in healthy children ages 5 to 11, the companies said on Thursday. ..
The Ministry of Public Health has approved the use of a fourth vaccine dose of Pfizer/BioNTech and Moderna COVID-19 vaccines for individuals at high-risk of severe infection. The fourth dose is only applicable to individuals 60 years of age ..